1993
DOI: 10.1007/978-1-4471-3479-4_13
|View full text |Cite
|
Sign up to set email alerts
|

Crystalline Bacterial Cell Surface Layers (S-Layers) as Combined Carrier/Adjuvants for Conjugate Vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1993
1993
2014
2014

Publication Types

Select...
4
2
2

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(6 citation statements)
references
References 25 publications
0
6
0
Order By: Relevance
“…Because a reproducible immobilization of peptide epitopes to common carriers which were used as monomers in solution or as dispersions of unstructured aggregates on aluminum salts could not be achieved (Brown et al ., ; Powell & Newman, ), the use of regularly structured S‐layer self‐assembly products as immobilization matrices was envisaged. Therefore, several conjugate vaccines with S‐layer (glyco)proteins and carbohydrate antigens (poly‐ and oligosaccharides), haptens or the recombinant birch pollen allergen Bet v1 were produced which showed promising results in vaccination trials (Sleytr et al ., ; Messner et al ., ; Malcolm et al ., , b; Smith et al ., ; Jahn‐Schmid et al ., , b; Messner et al ., ; Jahn‐Schmid et al ., ).…”
Section: Applicationsmentioning
confidence: 99%
“…Because a reproducible immobilization of peptide epitopes to common carriers which were used as monomers in solution or as dispersions of unstructured aggregates on aluminum salts could not be achieved (Brown et al ., ; Powell & Newman, ), the use of regularly structured S‐layer self‐assembly products as immobilization matrices was envisaged. Therefore, several conjugate vaccines with S‐layer (glyco)proteins and carbohydrate antigens (poly‐ and oligosaccharides), haptens or the recombinant birch pollen allergen Bet v1 were produced which showed promising results in vaccination trials (Sleytr et al ., ; Messner et al ., ; Malcolm et al ., , b; Smith et al ., ; Jahn‐Schmid et al ., , b; Messner et al ., ; Jahn‐Schmid et al ., ).…”
Section: Applicationsmentioning
confidence: 99%
“…Secondary and tertiary immunization could be performed using the same hapten(s) coupled to different immunologically non-cross-reactive S-layers, thus preventing the tolerance frequently observed with toxoid carriers. The data gathered also showed that S-layers vaccines have an intrinsic adjuvant property Malcolm et al 1993).…”
Section: Conjugated Vaccinesmentioning
confidence: 88%
“…An even broader application potential for S-layers can be seen in their use as immobilization matrix and adjuvant for weakly immunogenic antigens and haptens Messner et al 1992a;Malcolm et al 1993). Both glycosylated and non-glycosylated S-layers have been used as vaccine carriers.…”
Section: Conjugated Vaccinesmentioning
confidence: 99%
See 1 more Smart Citation
“…S-layer proteins have been crystallized and cross-linked on the surface of liposomes to stabilize the lipid membrane by modulating the lateral diffusion of the free lipid molecules, thus changing their fluidity and increasing their mechanical stability (Paul et al, 1992). And the suitability of S-layers as carrier/adjuvants for the production of conjugate vaccines has been described by Malcolm et al (1993).…”
Section: Immobilization Matrix/carriersmentioning
confidence: 99%